HitIQ Ltd Announces Strategic Developments Amidst Financial Movements

In a series of strategic announcements, HitIQ Ltd, a prominent player in the health care sector specializing in concussion management technologies, has unveiled significant developments that could shape its future trajectory. Based in South Melbourne, Australia, HitIQ is known for its innovative mouthguards and sports equipment, serving a global customer base. The company’s recent activities, including a proposed securities issue and a notable agreement with Shock Doctor, Inc., underscore its commitment to growth and innovation.

Proposed Securities Issue

On June 16, 2025, HitIQ Ltd announced its intention to issue 4,090,909 ordinary shares fully paid, set for placement on June 17, 2025. This move is part of a broader strategy to bolster the company’s financial standing and support its expansion plans. The issuance of these securities is a critical step for HitIQ, reflecting its proactive approach to capital management and its ambition to enhance shareholder value. The company’s market cap stands at 10,140,000 AUD, with a close price of 0.018 AUD as of June 12, 2025, indicating a potential for growth as it navigates through its strategic initiatives.

Debt Conversion Agreement with Forward Intellectual Property Pty Ltd

In a related development, HitIQ Ltd has entered into a debt conversion agreement with Forward Intellectual Property Pty Ltd (Forward) to settle $90,000 worth of intellectual property services. This agreement involves the issuance of 4,090,909 ordinary shares at a deemed price of $0.022 per share, utilizing the company’s ASX Listing Rule 7.1 placement capacity. This strategic move not only addresses the company’s immediate financial obligations but also strengthens its intellectual property portfolio, a critical asset in the competitive health care sector.

Exclusive Global Agreement with Shock Doctor, Inc.

Further solidifying its position in the market, HitIQ Ltd has entered into an exclusive global agreement with Shock Doctor, Inc., for the PROTEQT mouthguard. This five-year agreement, renewable for another five years, involves the co-branding of the HITIQ/SHOCK PROTEQT mouthguard chassis, with Stang Precision manufacturing the product using bespoke tooling. This partnership is significant for HitIQ, as it enhances its product offering and distribution capabilities, particularly in Australia and the UK. The agreement is fully binding, with no conditions, highlighting the strong mutual commitment between HitIQ and Shock Doctor, Inc.

Looking Ahead

These strategic developments are indicative of HitIQ Ltd’s forward-looking approach and its commitment to innovation and growth in the health care sector. By strengthening its financial position through the proposed securities issue, addressing its intellectual property needs, and expanding its product offerings through strategic partnerships, HitIQ is well-positioned to capitalize on emerging opportunities in the concussion management space. As the company continues to navigate the challenges and opportunities ahead, its actions today will undoubtedly shape its trajectory in the years to come.